The Era of Big Pharma Fraud Cases May Be Ending
A recent interview with former US Attorney Michael K. Loucks noted that although “The Era of Big Pharma Fraud Cases Is Ending,”…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
March 2010
News Paper Targets Private Practice Physicians Speaking at Industry Events
As part of an ongoing series about how money and conflicts of interest affect medicine and patient care, the Milwaukee Journal…
Congressional Hearing on Drug Safety: an Update from the FDA
Last week, The House Committee on Energy and Commerce, Subcommittee on Health held a hearing on “Drug Safety: An Update from the…
Health Care Reform: Democrat Congressman Calls for Starting from the…
This week Congress is in the final leg of passing health care reform, and politicians are gathering as many votes to save…
Continuing Education Reform: Are We Throwing the Baby Out With the…
Recent evaluations of professional societies and accredited continuing medical education (CME) providers have “further…
FDA Educates Industry on Development of Orphan Drugs
In the complex and expensive world of research and development for drugs, there are therapies for conditions known as “orphan…
ACC 2010 Features Debate on Industry Support of Education
On Tuesday March 16th at 8:00am, there will be a debate at the American College of Cardiology Meeting in Altanta Georgia on…
Nature Editorial: Building Bridges not Barriers
An editorial in Nature used the recent appointment of William Chin as a perfect example of why “industry talent should be…
GAO Recommends the FDA to Strengthen Investigation Oversight
Within the Food and Drug Administration (FDA) is the Office of Criminal Investigations (OCI), which investigates individuals and…
Connecticut Debates Bill to Limit Physician Industry Interaction
During testimony last week at a Public Health Committee hearing for the Connecticut General Assembly, Connecticut Attorney General…